Human-Immunodeficiency-Virus Type-1 Env and P17(Gag) Sequence Variation in Polymerase Chain Reaction-Positive, Seronegative Injection-Drug Users

RB MARKHAM,XF YU,H FARZADEGAN,SC RAY,D VLAHOV
DOI: https://doi.org/10.1093/infdis/171.4.797
1995-01-01
Abstract:Variation in gene sequences from human immunodeficiency virus type 1 (HIV-1) p17(gag) and the third hypervariable region (V3 loop) of env was examined in a cross-sectional study of single specimens from 4 HIV-1 polymerase chain reaction-positive, seronegative injection drug users. As observed in sexually transmitted disease, clones of HIV-1 genes isolated from an individual were remarkably homogeneous, with amino acid variation in the envelope region of 0.3%-0.9% and in p17(gag) of 0.0%-0.7%. Intersubject variation was much greater (at the amino acid level, 15% for the envelope and 4.3% for p17(gag)), with conservation in the envelope only of regions at the base of the V3 loop. Since at least some subjects likely acquired infection intravenously, the ability of virus to survive in seminal fluid or on mucosal surfaces cannot explain the observed homogeneity, which may depend on direct interactions between the virus and the infected cell.
What problem does this paper attempt to address?